Washington Biotechnology
  • In Vivo CRO Services
    • Autoimmune & Inflammatory Diseases
      • Multiple Sclerosis
      • Gout
      • Inflammatory Bowel Disease (IBD)
      • Dermatitis (Contact)
      • Lupus
      • Nephritis
      • Pancreatitis
      • Hepatitis
      • Psoriasis
      • Pulmonary Fibrosis
      • Diabetes
      • General Inflammation Assessment
      • Acute Choleostasis Model
    • Rheumatoid Arthritis
      • Collagen-Induced Arthritis Model
      • Adjuvant-Induced Arthritis Model
      • Carrageenan Air Pouch Model
      • Zymosan Air Pouch Model
      • Pristane-Induced Arthritis Model
      • Ovalbumin-Induced Arthritis Model
      • SCW PG-PS 10S Rat Model
      • Arthritis Combo Testing: Rodent/Rabbit
    • Cancer
      • WBI Cell Lines for Cancer Models
      • Xenograft, Orthotopic & Syngeneic Models
    • Bacterial Infection
      • MRSA Model
      • Listeria Model
    • Pain Studies
      • Formalin Test (Chemical Sensitivity)
    • Pharmacokinetics and Toxicity
      • Pharmacokinetics (PK)
      • Toxicity and MTD Studies
    • Support Services
      • In Vitro Compound Screening for Anti-inflammatory Activity
    • WBI Project Management
  • About Us
  • What's New
  • Contact Us
  • Sitemap
  • Careers
  • In Vivo CRO Services
    • Autoimmune & Inflammatory Diseases
    • Rheumatoid Arthritis
      • Collagen-Induced Arthritis Model
      • Adjuvant-Induced Arthritis Model
      • Carrageenan Air Pouch Model
      • Zymosan Air Pouch Model
      • Pristane-Induced Arthritis Model
      • Ovalbumin-Induced Arthritis Model
      • SCW PG-PS 10S Rat Model
      • Arthritis Combo Testing: Rodent/Rabbit
    • Cancer
    • Bacterial Infection
    • Pain Studies
    • Pharmacokinetics and Toxicity
    • Support Services
    • WBI Project Management
  • About Us
  • What's New
  • Contact Us
  • Sitemap
  • Careers

Rheumatoid Arthritis

 

Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of joints and organs.

WBI’s models for Rheumatoid Arthritis (RA) cover all of the essential models for evaluation of anti-arthritic efficacy for small molecules, proteins and vaccines. Our scientists are experienced with evaluation of results for test materials and a wide variety of controls/reference materials used in hundreds of our prophylactic and therapeutic studies.

In addition to the basic read-outs for each model, optional analyses can be ordered for histopathology, cytokines, pharmacokinetic samples and collagen antibodies.

 

WBI's RA models

  • Collagen-Induced Arthritis (CIA)
  • Adjuvant-Induced Arthritis (AIA) 
  • Carrageenan Air Pouch
  • Zymosan Air Pouch
  • Pristane-Induced Arthritis (PIA)
  • Ovalbumin-Induced Arthritis (OIA)
  • SCW PG-PS 10S

 

Because no single test is definitive in predicting efficacy for treatment of humans, the importance of results from animal models in more than one species is recognized. Hence WBI offers a Two Species Test for Arthritis: Rodent/Rabbit Combo-Test for Arthritis for additional assurance of test material efficacy.

A Final Report for each of our studies includes all details of materials, procedures, observations, measurements, data and statistical analysis for treatment efficacy.

Contact Us
Request a Quote
What's New?
Read Our Newsletter

© Washington Biotechnology Inc., 2014. All Rights Reserved.
Built by Biz-Zone